Clinical Results

In cooperation with Mayo Clinic, PathRight Medical completed two clinical studies enrolling over 100 men total. The first trial compared men using RestoreX for 30, 60 or 90 minutes per day in 1,2 or 3 30-minute sessions against a control group, i.e. a group that did not do any treatment at all. A link to the 3 month appears below as well as a link to the same group followed out to 6 months. The 3 month results were published in the Journal of Urology in June 2019 and the 6 month results presented at a recent Urology conference (March 2019). Additionally, a study was completed using RestoreX in combination with Xiaflex injections. This study was also published and appeared in the Journal of Sexual Medicine in 2019. Click the link below to be directed to the study results of combination therapy with Xiaflex.

Key Findings include:

3-month data

Combination with Xiaflex

Clinical Study Results:

Clinical Results for Peyronies Disease

Preliminary clinical trial results are available from two ongoing studies at Mayo Clinic.

Clinical Results for Penile Lengthening

Two clinical studies are currently taking place to assess the ability of RestoreX to either restore lost length from chronic disease (diabetes) or to prevent the loss of length post-surgery (prostatectomy). Click either link below to see a summary of the preliminary trial results.

PathRight Medical was formed in 2015 to meaningfully improve the lives of men with Peyronie’s disease or those with side effects associated with urological surgeries or chronic disease. PathRight Medical developed RestoreX in cooperation with Mayo Clinic.

CE marking

Contact us

PathRight Medical, Inc.
1443 W 800 N
Suite 303
Orem, UT 84057

CALL: 1-877-228-5147

© Copyright 2024 PathRight Medical, Inc. All Rights Reserved.